Improving health is one of the toughest challenges facing the world today. As a global, innovation-driven biopharmaceutical company, AstraZeneca has a key contribution to make through the discovery, development, manufacturing and commercialisation of medicines for six important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.

AstraZeneca in the Gulf

As one of the leading pharmaceutical companies in the Gulf, AstraZeneca is focused on developing innovative medicines to treat diseases in important therapy areas impacting public health. Our success is based on our commitment to serving the needs of the patients and improving their health.

We believe in maintaining high ethical standards of business practice. Aiming to effectively manage that responsibility, we find new ways of bringing benefit to society and thereby ensure that AstraZeneca continues to be welcomed as a valued member of the local community.



  • Brilinta
  • Crestor
  • Atacand/Atacand Plus
  • Plendil
  • Tenormin/Tenoretic
  • Zestril/Zestoretic
  • Inderal
  • Betaloc/Betaloc ZOK


Diabetes (in partnership with Bristol-Myers Squibb)

  • Onglyza
  • Kombiglyze



  • Nexium
  • Losec
  • Entocort



  • Meronem



  • Diprivan
  • Emla
  • Marcaine
  • Naropin
  • Seroquel
  • Xylocaine
  • Zomig



  • Arimidex
  • Casodex
  • Nolvadex
  • Zoladex


  • Bricanyl
  • Oxis
  • Pulmicort
  • Rhinocort
  • Symbicort

Adverse event reporting

If you are taking any of AstraZeneca’s medicines and you experience an adverse event defined as;

“Development of an undesirable condition or deterioration of pre-existing medical condition following or during exposure to a pharmaceutical product, whether or not causally related to the product.”

Or would like to request information about AstraZeneca’s medicines, please contact our Patient Safety and Medical Information unit:

Mobile: +971 50 2865074

Phone: +971 4 3624888

Fax: +971 4 3624838


Interested in joining us?

AstraZeneca Gulf regional head office is located in Dubai (UAE) and has offices in Abu Dhabi, Kuwait, Bahrain, Qatar, and Oman.

As a growing company, we are continually seeking new medical representative positions and may also have vacancies (within the UAE) in Marketing, Finance, IS and HR for suitably qualified people.

We aim to stimulate continued creativity throughout our organisation by maintaining culture and diversity in which our people feel valued, energised and rewarded for their contribution to our success. We support and encourage our people in discovering their own potential, through excellent learning and development opportunities that are available to them throughout their careers. We are committed to help improve the lives of, and add value to, all those who benefit from it.

If you would like to apply to work for AstraZeneca Gulf, please register your interest by sending an email to , along with a covering letter stating the area/position for which you would like to apply e.g. Medical Rep, Product Manager etc.

Your CV will be forwarded to our HR Department for consideration and you will be advised if we have any suitable vacancies.

Thank you for your interest in AstraZeneca Gulf.


Please visit our corporate Media Centre to view current news and subscribe to e-mail alerts.


The Safe@Heart website acts as a one-stop online guide to better heart health. The website features tips and tricks on Being Safe, Eating Safe and Living Safe through a variety of information, articles, videos and links in both Arabic and English. The Safe@Heart website is also home to the 12 Week Programme, developed by a nutritionist based in the UAE as a step-by-step guide that charts a course through the necessary lifestyle and diet changes needed to improve heart health. The 12 Week Programme helps to increase knowledge on cholesterol, one of the major risk factors that can lead to heart attack, and explains the benefits of healthy foods and physical activity, alongside actions to apply daily.


Dubai Health Care City
Ibn Sina Bldg 27, D-Block, 2nd Floor
Oud Metha, PO Box 505070
Tel: +971 4 3624888
Fax: +971 4 3624899